ARTICLE | Clinical News
Tavocept: Phase III data
March 24, 2008 7:00 AM UTC
BioNumerik Pharmaceuticals Inc., San Antonio, Texas Product: Tavocept ( BNP7787) Business: Cancer Molecular target: DNA Description: Water soluble cisplatin Indication: Prevent/reduce paclitaxel- and...